Dr. Reddy's divests non-core brands in dermatology to Eris Lifesciences for Rs 275 Cr
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
Proposed combination enhances Pfizer’s position as a leading company in oncology
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Marksans' OTC Famotidine Tablets USP are acid reducers
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
Subscribe To Our Newsletter & Stay Updated